CompletedNot Applicable

Management of Nausea and Vomiting Chemotherapy-induced in Normandy

France300 participantsStarted 2011-07

Plain-language summary

The objective of this study was to evaluate the various parameters involved in the occurrence of nausea / vomiting during the first cycle of chemotherapy for solid tumors or hematologic among a group of chemotherapy-naive patients, despite anti standardized-emetics protocols.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged over 18 years * With solid tumors or hematologic in first line chemotherapy, administered intravenously, * Able to understand the meaning of the questions * Having given their written consent to participate in the survey. Exclusion Criteria: This does not concern patients who: * Do not give their consent for participation * Do not speak French * Suffer from cognitive deficits * Are under therapy * Must receive a combination of radio-chemotherapy * Present an occlusive syndrome * Metastases (s) brain (s) clinically symptomatic (s) or radiologically proven (s) or a (of) tumor (s) brain (s) * Have been previously treated with chemotherapy * Present a cons-indication to corticosteroids, with anti-serotonin or NK1 receptor inhibitors * Pregnant or breastfeeding.

What they're measuring

Number of Participants With Acute Nausea and Vomiting

Timeframe: 24 hours

Trial details

NCT IDNCT01440465

SponsorCentre Francois Baclesse

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-01

Results submitted2025-10-03

View on ClinicalTrials.gov More Cancer trials